News Ipsen's Cabometyx recommended by NICE for previously treated... French drugmaker Ipsen’s Cabometyx (cabozantinib) has been recommended by the National Institute for Health and Care
News PBM reform dropped in Congress' funding package Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
